Pharmabiz

DBV Technologies submits BLA to US FDA for Viaskin peanut patch in children aged 4 to 7 tears

DBV Technologies submits BLA to US FDA for Viaskin peanut patch in children aged 4 to 7 tears: Châtillon, France Thursday, October 1, 2026, 18:00 Hrs [IST] DBV Technologies, a la ...
Pharmabiz

Truevis Technologies and Neusoft to strengthen Pan-India medical imaging support

Truevis Technologies and Neusoft to strengthen Pan-India medical imaging support: Our Bureau, Mumbai Thursday, October 1, 2026, 15:45 Hrs [IST] Truevis Technologies Pvt. Ltd., in ...
Pharmabiz

Boehringer Ingelheim investments into sustainability-related programmes and health partnerships to reach EUR 500 million

Boehringer Ingelheim announced that it projects its investments into sustainability-related programmes and health partnerships that aim to help improve the lives of people, animals and their ...
Pharmabiz

Cold Chain Technologies launches reusable dry ice shipper for pharmaceuticals shipment protection

Cold Chain Technologies launches reusable dry ice shipper for pharmaceuticals shipment protection: United Kingdom Thursday, October 1, 2026, 13:00 Hrs [IST] Cold Chain Technologie ...
Pharmabiz

TriLink BioTechnologies receives additional patent from China for CleanCap technology

TriLink BioTechnologies receives additional patent from China for CleanCap technology: San Diego Thursday, October 1, 2026, 17:00 Hrs [IST] TriLink BioTechnologies LLC, part of Li ...
Pharmabiz

Hutchmed announces AstraZeneca submits NDA to US FDA for Orpathys plus Tagrisso in MET-driven EGFR-mutated lung cancer

Hutchmed announces AstraZeneca submits NDA to US FDA for Orpathys plus Tagrisso in MET-driven EGFR-mutated lung cancer: Hong Kong, Shanghai Thursday, October 1, 2026, 14:00 Hrs [I ...
Pharmabiz

Longevity healthcare startup Vytalyou raises Rs. 9 crore to expand clinic network

Longevity healthcare startup Vytalyou raises Rs. 9 crore to expand clinic network: Our Bureau, Mumbai Thursday, October 1, 2026, 13:30 Hrs [IST] Vytalyou, a doctor-led longevity a ...
Pharmabiz

Healthark sets agenda for next Generation of Life Sciences and HealthTech GCCs at RISE 2026

Healthark sets agenda for next Generation of Life Sciences and HealthTech GCCs at RISE 2026: Our Bureau, Mumbai Thursday, October 1, 2026, 11:30 Hrs [IST] Healthark, a healthcare ...
Pharmabiz

Shilpa Biologicals launches SB HiMax platform at CPHI Milan

Shilpa Biologicals, a subsidiary of Shilpa Medicare , launches its new gene to GMP manufacturing platform, SB HiMax which ...
Pharmabiz

Acrotech Biopharma launches Adquey in US

Acrotech Biopharma Inc., a biopharmaceutical company focused on developing and commercializing innovative proprietary medicines, announced the US launch of Adquey (difamilast 1%) ointment, a ...
Pharmabiz

Takeda announces positive data from three phase 3 LATITUDE psoriasis studies of zasocitinib in adults with moderate-to-severe plaque psoriasis

Takeda announces positive data from three phase 3 LATITUDE psoriasis studies of zasocitinib in adults with moderate-to-severe plaque psoriasis: Osaka, Japan Thursday, October 1, 2 ...
Pharmabiz

Merck’s tulisokibart meets primary and key secondary endpoints in phase 2b study in patients with moderate to severe hidradenitis suppurativa

Merck’s tulisokibart meets primary and key secondary endpoints in phase 2b study in patients with moderate to severe hidradenitis suppurativa: Rahway, New Jersey Thursday, Octob ...